J-PHARMA
J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where people with specific diseases are treated with novel and selective agents. J-Pharma’s intellectual property (IP) embraces the notion that cell membrane transporters are tightly associated to many diseases. In addition to drug molecules that target specific transporters, J-Pharma has discovered several important drug transporters within the human body t... hat may be used to evaluate and optimize pharmacokinetics of new drug candidates. We believe that J-Pharma’s pipelines will lead to new agents and processes (i.e. diagnostic methods) and will increase the quality of life for an ageing population in industrialized countries. J-Pharma’s overall goal is to contribute globally to the maintenance of human health and improve human welfare through the creation of new drugs.
J-PHARMA
Industry:
Biotechnology Medical Nursing And Residential Care
Founded:
2005-12-26
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.j-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+81-45-506-1155
Email Addresses:
[email protected]
Total Funding:
4.83 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series D - J-Pharma
Eight Roads Ventures
Eight Roads Ventures investment in Series D - J-Pharma
KNC Laboratories
KNC Laboratories investment in Series D - J-Pharma
Sansei Capital Investment
Sansei Capital Investment investment in Series D - J-Pharma
Osaka University Venture Capital
Osaka University Venture Capital investment in Series D - J-Pharma
Nippon Venture Capital
Nippon Venture Capital investment in Series D - J-Pharma
MBLVC
MBLVC investment in Series D - J-Pharma
QB Capital
QB Capital investment in Series D - J-Pharma
Ohara Pharmaceutical
Ohara Pharmaceutical investment in Series D - J-Pharma
Spera Pharma
Spera Pharma investment in Series D - J-Pharma
Official Site Inspections
http://www.j-pharma.com
- Host name: yellow-giraffe-877fc30df65672a2.znlc.jp
- IP address: 164.46.119.154
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "J-Pharma"
Organization and Personnel Changes | ジェイファーマ株式会社
February 26,2021 J-Pharma Co., Ltd. PDF For Print. Yokohama, Japan, February 26, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes …See details»
Organization and Personnel Changes | ジェイファーマ株式会社
Mar 16, 2021 J-Pharma Co., Ltd. PDF For Print. Yokohama, Japan, March 19, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes. …See details»
J-Pharma - Crunchbase Company Profile & Funding
J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where …See details»
Interviews with leading Life Sciences companies: J …
May 26, 2023 J-Pharma is a frontrunner in developing inhibitors of L-type amino acid transporter for treating advanced refractory cancers and autoimmune diseases. Learn more about the Yokohama-based organization in this …See details»
J-Pharma Co., Ltd. (J-Pharma Co., Ltd.) - 药物管线_专利_临床试验_ …
May 7, 2025 项与 J-Pharma Co., Ltd. 相关的文献（医药） 2024-05-01 · Journal of Pharmacological Sciences Upregulation of ATF4 mediates the cellular adaptation to …See details»
J-Pharma - Overview, News & Similar companies | ZoomInfo.com
Aug 27, 2020 J-Pharma contact info: Phone number: +81 455061155 Website: www.j-pharma.com What does J-Pharma do? We are pleased to inform you that we have raised a …See details»
J-Pharma - Contacts, Employees, Board Members, Advisors & Alumni
J-Pharma is biotechnology company that aims to create new possibilities for membrane transporters and develops new pharmaceuticals. New. Resources. Advanced Search. Start …See details»
J-Pharma Co., Ltd. - BIO International Convention | BIO
J-Pharma is a biotech venture established based on technologies developed at Kyorin University. The company is developing a novel drug by leveraging its intellectual properties related to cell membrane transport proteins. Currently, J …See details»
J-Pharma - Funding, Financials, Valuation & Investors - Crunchbase
Venture Round - J-Pharma . 1: obfuscated. obfuscated. Iwagin Jigyo Souzou Capital: Jan 1, 2013: Venture Round - J-Pharma . 1: obfuscated. obfuscated — Investors. Edit Investors Section. …See details»
J-Pharma
2025.04.01 J-Pharma Raises Maximum ¥5.77 Billion in Funding Accelerates Global Development of LAT1 Inhibitors ; 2025.02.26 Notice of Board of Directors Appointments ; View More. Please contact us from here. Contact. J-Pharma …See details»
J-Pharma Co., Ltd. | Global Startup Acceleration Program (GSAP) …
Global Startup Acceleration Program (GSAP) Alumnis J-Pharma Co., Ltd. CIC '21 Bio/Healthcare Healthcare Manufacturing Chemistry Biotech Website; From its establishment in 2005 by …See details»
JPH-034 - Drug Targets, Indications, Patents - Synapse - Patsnap
6 days ago JPH-034: a SLC7A5 inhibitors Drug, Initially developed by J-Pharma Co., Ltd., Now, its global highest R&D status is Phase 2, Mechanism: SLC7A5 inhibitors(L-type amino acid …See details»
J-Pharma Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Literatures (Medical) associated with J-Pharma Co., Ltd. 01 May 2024 · Journal of pharmacological sciences Upregulation of ATF4 mediates the cellular adaptation to …See details»
ジェイファーマ株式会社 | YOKOHAMA STARTUP HUB | 横浜未来 …
新規抗がん療法の研究、開発。 細胞膜に存在するタンパク質で、細胞内外への物質輸送を担う膜タンパク質の構造物「トランスポーター」を標的とした薬の開発。See details»
Johnson & Johnson: Changing health for humanity
Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives.See details»
ジェイファーマ株式会社｜SLCトランスポーター創薬
Business SLCトランスポーターの可能性を開拓し、 不治の疾患に対する新しい治療法を創出する. 当社は、『SLCトランスポーターの新たな可能性を追求し、アンメット・メディカル・ …See details»
Governance - Corporate governance overview | Johnson
Procedures for Handling Shareholder and Other Communications to the Board. Any communications directed to the Board of Directors, the Lead Director or any other member of …See details»
Business | J-Pharma
J-Pharma Co., Ltd. 〒230-0046 Leading Venture Plaza 1 75-1 Onocho, Tsurumi-ku, Yokohama, 230-0046 Japan TEL 045-506-1155 / FAX 045-506-1156See details»
JPH-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
JPH-101: a Phosphate-binding proteins modulators Drug, Initially developed by J-Pharma Co., Ltd., Now, its global highest R&D status is Discontinued, Mechanism: Phosphate-binding …See details»
Verona Pharma Reports First Quarter 2025 Financial Results and …
Apr 29, 2025 Verona Pharma will host a live webcast and a conference call at 9:00 a.m. EDT / 2:00 p.m. BST on Tuesday, April 29, 2025, to discuss the first quarter 2025 financial results …See details»